Concord Drugs (BOM:538965) Total Assets : ₹0.0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Total Assets?

Concord Drugs's Total Assets for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

During the past 12 months, Concord Drugs's average Total Assets Growth Rate was 9.00% per year. During the past 3 years, the average Total Assets Growth Rate was 0.10% per year. During the past 5 years, the average Total Assets Growth Rate was -11.60% per year.

During the past 10 years, Concord Drugs's highest 3-Year average Total Assets Growth Rate was 25.20%. The lowest was -22.30%. And the median was 0.85%.

Total Assets is connected with ROA %. Concord Drugs's annualized ROA % for the quarter that ended in Dec. 2023 was -1.64%. Total Assets is also linked to Revenue through Asset Turnover. Concord Drugs's Asset Turnover for the quarter that ended in Dec. 2023 was 0.22.

Concord Drugs Total Assets Historical Data

The historical data trend for Concord Drugs's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Total Assets Chart

Concord Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

827.69

580.16

498.83

564.45

582.31

Concord Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															-	582.31	-	589.05	-

Concord Drugs Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Concord Drugs's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	317.044	+	265.266
	=	582.3

Concord Drugs's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	N/A	+	N/A
	=	N/A

Concord Drugs (BOM:538965) Total Assets Explanation

Total Assets is connected with ROA %.

Concord Drugs's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-9.648	/	( (589.045	+	0)	/ 1 )
	=	-9.648	/	589.045
	=	-1.64 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Concord Drugs's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	127.837	/	( (589.045	+	0)	/ 1 )
=	127.837	/	589.045
=	0.22

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Concord Drugs Total Assets Related Terms

Thank you for viewing the detailed overview of Concord Drugs's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs (BOM:538965) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines